This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
GlaxoSmithKline has supported the Cancer Research Institute across patient education and thought leadership, providing sponsorship for the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, inaugural Immunotherapy Patient Summit, and multi-year sponsorship of the Immunotherapy Patient Summit series. In addition, GSK has provided unrestricted support to advance the Cancer Research Institute mission.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).